Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03324373
Title Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Yousef Zakharia

renal cell carcinoma


Everolimus + Lenvatinib

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.